| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Institute of Neurology, Queen Square, London, United Kingdom.
Address correspondence and reprint requests to Dr. J.C. Hobart, Neurological Outcome Measures Unit, Institute of Neurology, Queen Square, London WC1 N3BG, UK; e-mail: J.Hobart{at}ion.ucl.ac.uk
OBJECTIVE: The 36-item Short Form Health Survey Questionnaire (SF-36) is a widely used generic health status measure. Recently it has been adapted to produce a disease-specific measure for MS—the 54-item Multiple Sclerosis Quality of Life Scale (MSQOL-54)—composed of five unchanged SF-36 scales; three altered SF-36 scales (one item added to each scale); and five new scales incorporating 15 additional items. This study evaluates the impact of these additions by comparing the measurement properties of the MSQOL-54 with the SF-36.
METHODS: A total of 150 patients with MS, representing a broad spectrum of disease severity, completed a range of questionnaires, which included the MSQOL-54 (from which the SF-36 score was computed). Of these, 44 people completed the measures before and after inpatient rehabilitation to evaluate responsiveness. Standard psychometric methods were used to evaluate the measurement properties.
RESULTS: The measurement properties of the unchanged scales, inevitably, remain identical. Those of the three altered scales are virtually identical. Of the five new scales, the validity of the two sexual scales is questioned because of the high percentage of missing data, and the validity of the overall quality-of-life scale is limited as demonstrated by the low to moderate correlations with other related and unrelated measures. Responsiveness of the new scales also appears limited.
CONCLUSION: Modifying existing measures by simply adding clinically chosen items may not be as useful as anticipated in improving the measurement properties of an instrument.
This article has been cited by other articles:
|
|
 |
|
  M. Simeoni, P. Auquier, O. Fernandez, P. Flachenecker, S. Stecchi, C. Constantinescu, E. Idiman, A. Boyko, A. Beiske, T. Vollmer, et al. Validation of the Multiple Sclerosis International Quality of Life questionnaire Multiple Sclerosis, March 1, 2008; 14(2): 219 - 230. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Weisscher, B. Post, R. J. de Haan, C.A.W. Glas, J. D. Speelman, and M. Vermeulen The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease Neurology, December 4, 2007; 69(23): 2155 - 2161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Nicholl, J C Hobart, A F. Cramp, and A S Lowe-Strong Measuring quality of life in multiple sclerosis: not as simple as it sounds Multiple Sclerosis, December 1, 2005; 11(6): 708 - 712. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Heffernan and C. Jenkinson Review Paper: Measuring outcomes for neurological disorders: a review of disease-specific health status instruments for three degenerative neurological conditions Chronic Illness, June 1, 2005; 1(2): 131 - 142. [Abstract] [PDF]
|
|
|
|
|
|
D A Gruenewald, I J Higginson, B Vivat, P Edmonds, and R E Burman Quality of life measures for the palliative care of people severely affected by multiple sclerosis: a systematic review Multiple Sclerosis, December 1, 2004; 10(6): 690 - 725. [Abstract] [PDF]
|
|
|
|
|
|
L Nicholl, J Hobart, L Dunwoody, F Cramp, and A Lowe-Strong Measuring disability in multiple sclerosis: is the Community Dependency Index an improvement on the Barthel Index? Multiple Sclerosis, August 1, 2004; 10(4): 447 - 450. [Abstract] [PDF]
|
|
|
|
|
|
A Riazi, J C Hobart, D L Lamping, R Fitzpatrick, and A J Thompson Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales Multiple Sclerosis, August 1, 2003; 9(4): 411 - 419. [Abstract] [PDF]
|
|
|
|
|
|
M W Nortvedt and T Riise The use of quality of life measures in multiple sclerosis research Multiple Sclerosis, February 1, 2003; 9(1): 63 - 72. [Abstract] [PDF]
|
|
|
|
|
|
A. J Thompson Developing clinical outcome measures in multiple sclerosis: an evolving process Multiple Sclerosis, October 1, 2002; 8(5): 357 - 358. [PDF]
|
|
|
|
|
|
P Vermersch, J de Seze, B Delisse, S Lemaire, and T Stojkovic Quality of life in multiple sclerosis: influence of interferon-{beta}1a (Avonex(R)) treatment Multiple Sclerosis, October 1, 2002; 8(5): 377 - 381. [Abstract] [PDF]
|
|
|
|
 |
|
 C Pozzilli, M Brunetti, A M V Amicosante, C Gasperini, G Ristori, L Palmisano, and M Battaglia Home based management in multiple sclerosis: results of a randomised controlled trial J. Neurol. Neurosurg. Psychiatry, September 1, 2002; 73(3): 250 - 255. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
